ESC 365 - Beneficial effects of AT-001, an aldose reductase inhibitor, in rodent models of diabetic cardiomyopathy

HFA Premium Access

Beneficial effects of AT-001, an aldose reductase inhibitor, in rodent models of diabetic cardiomyopathy

Session: Clinical Forum - Sat.25 May 08:30 - Tues. 28 May at 12:30

Topic: Comorbidities

Speaker: Doctor R. Perfetti (New York, US)

Event: Heart Failure 2019

Congress Presentation

Add to my library

About the speaker

Doctor Riccardo Perfetti

New York (United States of America)

2 presentations

0 follower

14 more presentations in this session

STADE-HF: A Titration based on sST2 is safe but failed to decrease readmissions in patients admitted for acute heart failure.

Speaker: Mr J. Nicoleau (Montpellier, FR)

Clinical characteristics and prognosis of heart failure with mid-range ejection fraction: insights from a multi-centre

Speaker: Miss S. Lyu (Beijing, CN)

Interplay of stress regulatory transcription factors in human cardiac valvular disorders leading to heart failure and cross talk of NFAtc3 nuclear localization invitro.

Speaker: Professor I. Murtaza (Islamabad, PK)

Who is taking care of decompensations of patients after a de novo AHF episode? An outlook on the natural history through the NOVICA cohort

Speaker: Doctor O. Miro (Barcelona, ES)

Analysis on how the emergency physician decision of hospitalization or discharge home patients with acute heart failure matches with the risk categories stratified by the MEESSI scale

Speaker: Doctor O. Miro (Barcelona, ES)

Access the full session

Clinical Forum - Sat.25 May 08:30 - Tues. 28 May at 12:30

Speakers: Doctor R. Perfetti, Mr J. Nicoleau, Miss S. Lyu, Professor I. Murtaza, Doctor O. Miro...

About the event

Heart Failure 2019

25 May - 28 May 2019

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources